NCT01783964View on ClinicalTrials.gov

Elacytarabine Mass Balance Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

June 30, 2013

Conditions
Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects
Interventions
DRUG

[14C]-Elacytarabine

Single intravenous administration

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington, Nottngham

Sponsors

Lead Sponsor

Clavis Pharma
All Listed Sponsors
lead

Clavis Pharma

INDUSTRY

NCT01783964 - Elacytarabine Mass Balance Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter